Home › Funds › PALISADE CAPITAL MANAGEMENT, LP › HCSG
PALISADE CAPITAL MANAGEMENT, LP position in HCSG
HEALTHCARE SVCS GROUP INC COM · Health Care
PALISADE CAPITAL MANAGEMENT, LP reported holding 726,583 shares of HCSG (HEALTHCARE SVCS GROUP INC COM) in its Q2 2026 13F filing — a position valued at US$17.8M, representing 0.81% of its reported portfolio and ranking #23 among its reported holdings. PALISADE CAPITAL MANAGEMENT, LP has disclosed HCSG holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PALISADE CAPITAL MANAGEMENT, LP's HCSG position evolved
PALISADE CAPITAL MANAGEMENT, LP first disclosed a stake in HCSG in Q3 2023 at 1,639,599 shares (US$17.1M). The position peaked in Q4 2025 at 1,927,445 shares, worth US$36.9M. Across 12 filings, PALISADE CAPITAL MANAGEMENT, LP increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 726,583 shares valued at US$17.8M — a reduction of -795,880 shares quarter over quarter.. Notable position changes include a 28% increase in Q3 2024 (shares rose 4% over the following quarter), a 52% trim in Q2 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.64M | $17.10M | New |
| Q4 2023 | 1.46M | $15.18M | Reduce |
| Q1 2024 | 1.51M | $18.81M | Add |
| Q2 2024 | 1.48M | $15.67M | Reduce |
| Q3 2024 | 1.90M | $21.19M | Add |
| Q4 2024 | 2.22M | $25.75M | Add |
| Q1 2025 | 2.24M | $22.56M | Add |
| Q2 2025 | 2.18M | $32.71M | Reduce |
| Q3 2025 | 2.15M | $36.23M | Reduce |
| Q4 2025 | 1.93M | $36.85M | Reduce |
| Q1 2026 | 1.52M | $28.24M | Reduce |
| Q2 2026 | 726.58K | $17.84M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HCSG and 13F data
HCSG (HEALTHCARE SVCS GROUP INC COM) is a Health Care company. 38 other funds we track also report a position in HCSG — the largest reported positions include Royce & Associates (US$55.0M), ROYCE & ASSOCIATES LP (US$55.0M), Marathon Asset Management Ltd (US$18.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HCSG
- Royce & Associates 2.24M sh · $55.00M · Q2 2026
- ROYCE & ASSOCIATES LP 2.24M sh · $55.00M · Q2 2026
- Marathon Asset Management Ltd 759.82K sh · $18.66M · Q2 2026
- Pembroke Management, LTD 523.23K sh · $12.85M · Q2 2026
More on PALISADE CAPITAL MANAGEMENT, LP
FAQ
How long has PALISADE CAPITAL MANAGEMENT, LP held HCSG?
PALISADE CAPITAL MANAGEMENT, LP has disclosed HCSG holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is PALISADE CAPITAL MANAGEMENT, LP's current position in HCSG?
As of Q2 2026, PALISADE CAPITAL MANAGEMENT, LP holds 726.58K shares of HCSG (HEALTHCARE SVCS GROUP INC COM), valued at $17.84M, representing 0.81% of its reported portfolio and ranking #23.
Has PALISADE CAPITAL MANAGEMENT, LP been buying or selling HCSG?
In the latest 13F filing (Q2 2026), PALISADE CAPITAL MANAGEMENT, LP reduced its position in HCSG. The position peaked in Q4 2025 at 1.93M shares.
Which other funds hold HCSG?
Other major institutional holders of HCSG include Royce & Associates, ROYCE & ASSOCIATES LP, Marathon Asset Management Ltd, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.